Skip to main content
. 2024 Jul 29;16:1277–1283. doi: 10.2147/IJWH.S472628

Figure 2.

Figure 2

Chest and abdominal enhanced computed tomography(CT) scans show lung metastases before and after anlotinib and T-DXd therapy. (A) lung metastases before anlotinib and T-DXd therapy; (B) partial response in lung metastases after anlotinib and T-DXd treatment.